The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Oct. 30, 2018
Filed:
May. 02, 2014
Applicants:
Centre National DE LA Recherche Scientifique, Paris, FR;
Universite Paris-sud Xi, Orsay, FR;
Inventor:
Kawthar Bouchemal, Palaiseau, FR;
Assignees:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE, Paris, FR;
UNIVERSITE PARIS-SUD XI, Orsay, FR;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 47/42 (2017.01); A61K 8/64 (2006.01); A61K 8/65 (2006.01); A61K 8/67 (2006.01); A61K 47/40 (2006.01); A61K 8/11 (2006.01); A61Q 19/02 (2006.01); A61Q 19/04 (2006.01); A61Q 19/06 (2006.01); A61Q 19/08 (2006.01); A61Q 19/10 (2006.01); C08B 37/16 (2006.01); A61K 47/48 (2006.01); C08H 1/00 (2006.01); A61Q 13/00 (2006.01); A61Q 15/00 (2006.01); A61Q 17/04 (2006.01); A61K 8/73 (2006.01); A61Q 19/00 (2006.01); A61K 38/16 (2006.01); A61K 38/39 (2006.01); A61K 9/50 (2006.01);
U.S. Cl.
CPC ...
A61K 47/42 (2013.01); A61K 8/11 (2013.01); A61K 8/64 (2013.01); A61K 8/645 (2013.01); A61K 8/65 (2013.01); A61K 8/738 (2013.01); A61K 9/5036 (2013.01); A61K 9/5052 (2013.01); A61K 9/5057 (2013.01); A61K 38/168 (2013.01); A61K 38/39 (2013.01); A61K 47/40 (2013.01); A61K 47/48969 (2013.01); A61Q 13/00 (2013.01); A61Q 15/00 (2013.01); A61Q 17/04 (2013.01); A61Q 19/00 (2013.01); A61Q 19/008 (2013.01); A61Q 19/02 (2013.01); A61Q 19/04 (2013.01); A61Q 19/06 (2013.01); A61Q 19/08 (2013.01); A61Q 19/10 (2013.01); C08B 37/0015 (2013.01); C08H 1/00 (2013.01); A61K 2800/56 (2013.01);
Abstract
Microparticles and nanoparticles of hydrophobized proteins and an alpha-cyclodextrin, obtained by auto-association in an aqueous medium, the hydrophobized protein being obtained by grafting of alkyl chains coming from fatty acids, by an acylation reaction. These microparticles and nanoparticles constitute systems used for encapsulation of active substances of interest, in particular in the pharmaceutical field, and the vectorization thereof for therapeutic purposes.